These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 21931653)

  • 1. Donepezil impairs memory in healthy older subjects: behavioural, EEG and simultaneous EEG/fMRI biomarkers.
    Balsters JH; O'Connell RG; Martin MP; Galli A; Cassidy SM; Kilcullen SM; Delmonte S; Brennan S; Meaney JF; Fagan AJ; Bokde AL; Upton N; Lai R; Laruelle M; Lawlor B; Robertson IH
    PLoS One; 2011; 6(9):e24126. PubMed ID: 21931653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive effects of the acetylcholinesterase inhibitor, donepezil, in healthy, non-treatment seeking smokers: a pilot feasibility study.
    Ashare RL; Ray R; Lerman C; Strasser AA
    Drug Alcohol Depend; 2012 Nov; 126(1-2):263-7. PubMed ID: 22595038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of donepezil on sleep and REM sleep EEG in patients with Alzheimer disease: a double-blind placebo-controlled study.
    Moraes Wdos S; Poyares DR; Guilleminault C; Ramos LR; Bertolucci PH; Tufik S
    Sleep; 2006 Feb; 29(2):199-205. PubMed ID: 16494088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholinergic augmentation with donepezil enhances recovery in short-term memory and sustained attention after traumatic brain injury.
    Zhang L; Plotkin RC; Wang G; Sandel ME; Lee S
    Arch Phys Med Rehabil; 2004 Jul; 85(7):1050-5. PubMed ID: 15241749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donepezil for treatment of cognitive dysfunction in children with Down syndrome aged 10-17.
    Kishnani PS; Heller JH; Spiridigliozzi GA; Lott I; Escobar L; Richardson S; Zhang R; McRae T
    Am J Med Genet A; 2010 Dec; 152A(12):3028-35. PubMed ID: 21108390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methodological improvements in quantifying cognitive change in clinical trials: an example with single-dose administration of donepezil.
    Pietrzak RH; Maruff P; Snyder PJ
    J Nutr Health Aging; 2009 Mar; 13(3):268-73. PubMed ID: 19262966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and tolerability of high-dose (23 mg/d) versus standard-dose (10 mg/d) donepezil in moderate to severe Alzheimer's disease: A 24-week, randomized, double-blind study.
    Farlow MR; Salloway S; Tariot PN; Yardley J; Moline ML; Wang Q; Brand-Schieber E; Zou H; Hsu T; Satlin A
    Clin Ther; 2010 Jul; 32(7):1234-51. PubMed ID: 20678673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of donepezil, an acetylcholinesterase inhibitor, on neurogenesis in a rat model of vascular dementia.
    Kwon KJ; Kim MK; Lee EJ; Kim JN; Choi BR; Kim SY; Cho KS; Han JS; Kim HY; Shin CY; Han SH
    J Neurol Sci; 2014 Dec; 347(1-2):66-77. PubMed ID: 25266713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group.
    Rogers SL; Farlow MR; Doody RS; Mohs R; Friedhoff LT
    Neurology; 1998 Jan; 50(1):136-45. PubMed ID: 9443470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donepezil improves episodic memory in young individuals vulnerable to the effects of sleep deprivation.
    Chuah LY; Chong DL; Chen AK; Rekshan WR; Tan JC; Zheng H; Chee MW
    Sleep; 2009 Aug; 32(8):999-1010. PubMed ID: 19725251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute cognitive effects of donepezil in young, healthy volunteers.
    Zaninotto AL; Bueno OF; Pradella-Hallinan M; Tufik S; Rusted J; Stough C; Pompéia S
    Hum Psychopharmacol; 2009 Aug; 24(6):453-64. PubMed ID: 19637397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Network dynamics predict improvement in working memory performance following donepezil administration in healthy young adults.
    Reches A; Laufer I; Ziv K; Cukierman G; McEvoy K; Ettinger M; Knight RT; Gazzaley A; Geva AB
    Neuroimage; 2014 Mar; 88():228-41. PubMed ID: 24269569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease.
    Krishnan KR; Charles HC; Doraiswamy PM; Mintzer J; Weisler R; Yu X; Perdomo C; Ieni JR; Rogers S
    Am J Psychiatry; 2003 Nov; 160(11):2003-11. PubMed ID: 14594748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial.
    Black S; Román GC; Geldmacher DS; Salloway S; Hecker J; Burns A; Perdomo C; Kumar D; Pratt R;
    Stroke; 2003 Oct; 34(10):2323-30. PubMed ID: 12970516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maintenance treatment of depression in old age: a randomized, double-blind, placebo-controlled evaluation of the efficacy and safety of donepezil combined with antidepressant pharmacotherapy.
    Reynolds CF; Butters MA; Lopez O; Pollock BG; Dew MA; Mulsant BH; Lenze EJ; Holm M; Rogers JC; Mazumdar S; Houck PR; Begley A; Anderson S; Karp JF; Miller MD; Whyte EM; Stack J; Gildengers A; Szanto K; Bensasi S; Kaufer DI; Kamboh MI; DeKosky ST
    Arch Gen Psychiatry; 2011 Jan; 68(1):51-60. PubMed ID: 21199965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmenting atypical antipsychotics with a cognitive enhancer (donepezil) improves regional brain activity in schizophrenia patients: a pilot double-blind placebo controlled BOLD fMRI study.
    Nahas Z; George MS; Horner MD; Markowitz JS; Li X; Lorberbaum JP; Owens SD; McGurk S; DeVane L; Risch SC
    Neurocase; 2003 Jun; 9(3):274-82. PubMed ID: 12925933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of donepezil on cortical activation in mild cognitive impairment: a pilot double-blind placebo-controlled trial using functional MR imaging.
    Petrella JR; Prince SE; Krishnan S; Husn H; Kelley L; Doraiswamy PM
    AJNR Am J Neuroradiol; 2009 Feb; 30(2):411-6. PubMed ID: 19001543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropsychological test performance in healthy volunteers before and after donepezil administration.
    Beglinger LJ; Gaydos BL; Kareken DA; Tangphao-Daniels O; Siemers ER; Mohs RC
    J Psychopharmacol; 2004 Mar; 18(1):102-8. PubMed ID: 15107192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donepezil for cognitive impairment in Parkinson's disease: a randomized controlled trial.
    Marder K
    Curr Neurol Neurosci Rep; 2002 Sep; 2(5):390-1. PubMed ID: 12169217
    [No Abstract]   [Full Text] [Related]  

  • 20. Additive effects of a cholinesterase inhibitor and a histamine inverse agonist on scopolamine deficits in humans.
    Cho W; Maruff P; Connell J; Gargano C; Calder N; Doran S; Fox-Bosetti S; Hassan A; Renger J; Herman G; Lines C; Verma A
    Psychopharmacology (Berl); 2011 Dec; 218(3):513-24. PubMed ID: 21644059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.